Amicus Therapeutics, Inc. Stock
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-04-24 EDT
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-28 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
| Market Cap | 4.55B 3.93B 3.69B 3.36B 6.31B 435B 6.42B 43.27B 16.92B 218B 17.08B 16.71B 724B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.06B 3.81B 3.47B 6.52B 449B 6.63B 44.68B 17.47B 225B 17.64B 17.26B 748B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics, Inc.
| 1 day | +0.21% | ||
| 6 months | +1.26% | ||
| Current year | +1.76% |
| Current year | 14.2 |  | 14.5 |
| 1 year | 7.28 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | Fiscal year | Chief Executive Officer | 225,000 | 0.0727% | ||
| 1/2/26 | Tax | General Counsel | 43,109 | 0.0139% | ||
| 1/2/26 | Tax | Executive/Senior Manager | 30,007 | 0.0097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +103.51% | +9.03% | 4.55B | |
| -1.78% | -1.68% | +1.99% | +13.84% | 48.42B | |
| +0.85% | -0.70% | +465.55% | +579.03% | 43.66B | |
| -2.40% | -0.23% | +12.20% | +70.22% | 39.51B | |
| -2.01% | -0.85% | +24.95% | +7.51% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| -0.59% | -2.06% | +26.13% | +117.79% | 16.15B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| +0.49% | +0.92% | +4.32% | +22.16% | 14.16B | |
| -0.43% | +4.70% | +79.75% | +29.11% | 13.37B | |
| Average | -0.58% | +0.46% | +82.11% | +99.82% | 26.77B | |
| Weighted average by Cap. | -0.90% | +0.58% | +97.74% | +132.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 456M 429M 390M 733M 50.52B 745M 5.02B 1.96B 25.3B 1.98B 1.94B 84.07B | 634M 548M 515M 468M 880M 60.64B 895M 6.03B 2.36B 30.37B 2.38B 2.33B 101B |
| Net income | -56.11M -48.46M -45.54M -41.41M -77.86M -5.36B -79.14M -534M -209M -2.69B -211M -206M -8.93B | -27.11M -23.41M -22M -20.01M -37.62M -2.59B -38.24M -258M -101M -1.3B -102M -99.58M -4.31B |
| Net Debt | 194M 167M 157M 143M 269M 18.52B 273M 1.84B 720M 9.28B 727M 711M 30.82B | 149M 129M 121M 110M 207M 14.23B 210M 1.42B 553M 7.13B 559M 547M 23.68B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- FOLD Stock
Select your edition
All financial news and data tailored to specific country editions
